Clinical Trial Update: Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating node-sparing short-course radiotherapy with sequential chemotherapy and a PD-1 inhibitor for mid/low pMMR/MSS rectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 inhibitor (unspecified)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Cancer, Neoadjuvant Therapies | Phase 2, Phase 3 | Status: RECRUITING